Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : PYNG Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Stang who wrote (7865)	9/6/2005 12:25:38 PM
From: pictouislander	Respond to of 8117

Sorry Laura have no plans of retiring any time soon since i am young and love my work.I hope things work out for you with your investments because it wont be long before you will need full time care.

To: Stang who wrote (7865)	9/6/2005 1:39:31 PM
From: mf160	Respond to of 8117

Just waiting for the spin on this one. I am sure the date will be of issue. Oh and Stang you can a expect an attack on yourself that is a given. Response on this board relating directly to the letter you can forget about that. Well Natural and the rest of you this is exactly what we were warning you about. Did anyone ever see disclosure concerning this, it sounds material to me. I guess when one has the ego of mikey not even the FDA deserves respect. Keep it up mikey, just another FAST-1 eh!

To: Stang who wrote (7865)	9/6/2005 2:54:16 PM
From: Jack Rayfield	Read Replies (1) \| Respond to of 8117

Thanks for the information Stang. I am glad that you still occasionally check on us here. The oldtimers appreciate all that you have done to help us stay abreast of the developments that are not reported by Pyng. I agree with mf160 I would have thought that this "warning letter" would have required disclosure in the June 05 Q3 statements. There could be another "warning" coming from the Securities Commission regarding neglecting to make a required disclosure of a significant event. But your development will not be appreciated by the new comers to the forum as this is not positive news. Although since you provided the link to the actual letter they can not say this is negative rumor mongering like they did with LOR military sales report. I don't expect that Jacobs will respond as he has not posted on the forum since April 05. Since he bragged about the April monthly profit of then $137K then delivered only $140K for the quarter he has been pretty silent. I hope that this letter has not had an adverse effect on the military's willingness to order FAST1s to fill the Pyng reported tremendous need created by its inclusion in the TC(cubed) manual. Thanks again. Best Regards Jack

To: Stang who wrote (7865)	9/6/2005 4:59:41 PM
From: LOR	Read Replies (1) \| Respond to of 8117

Hi Stang, Nice to see that you are still out there. Just ignore any negative replies concerning your post. A couple of new-bees (natural-p and p-islander) may start groaning and moaning .....they being very wet behind the ears and deathly afraid that they won't be able to make a profit on the 500 shares they jointly own.... Thanks for the input and maybe this is why Jacob's has made efforts to attain ISO status etc. over the past year....OF COURSE, why worry the shareholders with his FDA problems....THAT would be too much like "disclosure" and we wouldn't want to upset the stake holders now would we..... All the best, LOR

To: Stang who wrote (7865)	9/6/2005 9:47:45 PM
From: make_me_rich	Respond to of 8117

Stang, Here is the contents of an email I sent with the response from MJ about a year ago regarding the FDA issues. MJ's response: Yes Steven this has been rectified. It was a procedural error that has been cleared up. Michael W. Jacobs, Pyng Medical Catherine Merryman Office Manager Pyng Medical Corporation 800-349-7964 x107 cmerryman@pyng.com -----Original Message----- Sent: August 20, 2004 8:19 PM To: info@pyng.com Subject: FDA Violations? Hi, Please see the attached link, which is the contents of a letter sent (April 9,2004) to Pyng by the FDA. Has this situation been rectified? Has there been any corporate announcements regarding this issue? fda.gov A concerned shareholder, Steve

To: Stang who wrote (7865)	9/7/2005 1:42:55 AM
From: naturalperson	Read Replies (1) \| Respond to of 8117

Are you guys for real? Stang and the rest on stangs bandwagon, have you read the current releases? It would seem that this old issue was taken care of long ago. Stop making out like it is a new development, that letter was posted on the net about a year ago, it has been dealt with. Read below. Pyng's management systems recertified after audit 2005-07-29 19:59 ET - News Release Mr. Michael Jacobs reports PYNG MEDICAL CORP RECERTIFIES ITS WORLD CLASS QUALITY MANAGEMENT SYSTEMS Pyng Medical Corp. has recertified its world-class quality management systems. A recent surveillance audit by S.G.S International, Pyng Medical-accredited third party registrar and notified body, was performed to ISO 9001:2000, ISO 13485:2003, Canadian medical device regulations and Medical Directive 93/42/EEC Annex II (excluding Section 4) for CE Marking. The company is already in full compliance to FDA's quality system requirements. The registration audit and the surveillance audit in both instances had no major non-conformances and also no minor non-conformances. This accomplishment is very significant in that Pyng Medical has now accomplished back-to-back audits with no non-conformances. This is testament to Pyng Medical adherence to producing high-quality product to all international standards under Pyng Medical quality-control management. Pyng Medical has had significant changes, including organizational restructuring, incredible growth, increased production and supplier changes, all of which tested the robustness of Pyng's quality systems. The S.G.S. International audit confirms the standards by which Pyng Medical is delivering its products. The company also recognizes the importance of its quality system, in-house production capacity, such as its class 10,000 clean room and engineering capabilities, as all being key and integral components of its strategic plan to broaden its product line. We seek Safe Harbor.